source Post navigation Type 2 Diabetes Pipeline Assessment, 2023 Updates | In-depth … – Digital Journal EXCLUSIVE: SAB Biotherapeutics' Type 1 Diabetes Candidate Moves One Step Closer To Enter Human Trials With Completion Of Toxicology Study – Yahoo Finance